Cited by 41Immune cells in cancerCancer Cells and MetastasisAngiogenesis and VEGF in Cancer

Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease

Open access
Charan, Manish, Dravid, Piyush, Cam, Maren, Setty, Bhuvana, Roberts, Ryan D., Houghton, Peter J., Cam, Hakan·2020·Oncotarget

Abstract

// Manish Charan 1 , Piyush Dravid 1 , Maren Cam 1 , Bhuvana Setty 2 , 4 , Ryan D. Roberts 1 , 4 , Peter J. Houghton 3 and Hakan Cam 1 , 4 1 Center for Childhood Cancer and Blood Diseases, Nationwide Children’s Hospital, Columbus, Ohio, USA 2 Department of Hematology & Oncology, Nationwide Children’s Hospital, Columbus, Ohio, USA 3 Greehey Children’s Cancer Research Institute, Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA 4 Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA Correspondence to: Hakan Cam, email: hcam@cscc.edu Keywords: pre-metastatic niche formation; osteosarcoma; ANGPTL2; tumor microenvironment; neutrophils Received: October 22, 2019 Accepted: December 28, 2019 Published: February 04, 2020 ABSTRACT The pre-metastatic niche (PMN) represents an abnormal microenvironment devoid of cancer cells, but favoring tumor growth. Little is known about the mechanisms that generate the PMN or their effects on host cells within metastasis-prone organs. Here, we investigated by using spontaneous metastatic models whether lung epithelial cells are essential for primary tumor induced neutrophil recruitment in lung and subsequently initiating PMN formation in osteosarcoma. We found that serum levels of ANGPTL2 in osteosarcoma patients are significantly higher compared to those in healthy controls and that ANGPTL2 secretion by tumor cells plays an essential role in osteosarcoma metastasis. We determined that tumor-derived ANGPTL2 stimulates lung epithelial cells, which is essential for primary tumor-induced neutrophil recruitment in lung and subsequent pre-metastatic niche formation. Lastly, we identified that a p63 isoform, ΔNp63, drives high level of ANGPTL2 secretion and pharmaceutical inhibition of ANGPTL2 signaling by a non–RGD-based integrin binding peptide (ATN-161) diminished metastatic load in lungs likely due to reduction of the lung pre-metastatic niche formation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.27433

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ANGPTL2 and the RANK-RANKL-OPG system have been identified as key contributors to formation of the pre-metastatic niche in the lung in osteosarcoma.

    “Similarly, ANGPTL2 77 and the RANK-RANKL-OPG system 78 have been identified as key contributors to the formation of the pre-metastatic niche in the lung.”

    From Osteosarcoma (2022) · cites this paper as [77]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Charan, M., Dravid, P., Cam, M., Setty, B., Roberts, R. D., Houghton, P. J., & Cam, H.
Affiliations
  • Nationwide Children's Hospital (US)
  • The University of Texas at San Antonio Health Science Center (US)
  • Center for Childhood Cancer and Blood Diseases, Nationwide Children’s Hospital, Columbus, Ohio, USA
Corresponding author
Cam, Maren
Venue
Oncotarget
Published
2020-02-04
Volume
11
Issue
5
Pages
510-522
ISSN
1949-2553 (ISSN-L)
OpenAlex
W3005312454
Cited by
41
References
45
Citations by year
2026: 4 · 2025: 4 · 2024: 10 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 5
FWCI
2.01
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Oncotarget (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Nationwide Children's Hospital (K08CA201638)
  • CancerFree KIDS
  • National Institutes of Health (UL1TR001070)
  • National Cancer Institute (P01CA165995, K08CA201638)
  • National Center for Advancing Translational Sciences
  • Hyundai Hope On Wheels
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
ANGPTL2, pre-metastatic niche, osteosarcoma, lung metastasis, neutrophil recruitment, lung epithelial cells, tumor microenvironment, ΔNp63, integrin-binding peptides, tumor-secreted factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review